Important US business magazine, Forbes, has crafted a list of the 100 most innovative companies on which the Danish medtech and pharma industry features prominently.
Coloplast makes it to number 12, and further down the list at number 70 diabetes giant Novo Nordisk is found.
The list is based on a so-called innovation premium, defined as “a measure of how much investors have bid up the stock price of a company above the value of its existing business based on expectations of future innovative results (new products, services and markets),” the magazine writes.
Moreover, companies on the list must have $10 billion in market capitalization, spend at least 2.5% of revenue on R&D and have seven years of public data.
In this regard, Coloplast and Novo scores an innovation premium of 46,5 % and 23,4 % respectively.
Life science fairs well
Generally speaking, the life science industry fairs well on Forbes’ innovation list. Two biotech companies, Alexion Pharmaceuticals (2) and Regeneron Pharmaceuticals (4), make it into the top 5.
Further down the list the medtech and pharmaceutical industries are represented by major corporations like Smith & Nephew (51), Valeant Pharmaceuticals (62), Covidien (67) og Mylan (90).
The only other Danish company on the list aside from Coloplast and Novo is Carlsberg, which slots in at 66.
Novo Nordisk tops global top 25 of biotechs
Novo among the 100 most valuable companies in the world
See the complete list from Forbes here.
Want to receive the latest news from Medwatch straight in your e-mail inbox? Sign up for our free english newsletter below.
Mere fra MedWatch
FDA giver særstatus til Snipr Biomes hovedaktiv
Snipr Biomes crispr-behandling af infektioner i blodstrømme for kræftpatienter har fået særstatus hos de amerikanske myndigheder.
Johnson & Johnson vil øge vaccinesalg med 46 procent i 2022
Johnson & Johnson vil sælge vacciner for 23 milliarder kroner i år. Konkurrenter vil sælge for langt mere.
Højere priser på råvarer og energi sender omkostningerne op hos Coloplast
Coloplast leverede tirsdag et kvartalsregnskab, der viste vækst på både top- og bundlinje, men højere priser på råvarer og energi samt tocifret løninflation i Ungarn betyder, at også medicoselskabets produktionsomkostninger har fået et løft i første kvartal.
KU søger chef til nyt life science-program
Københavns Universitet har indledt jagten på den programdirektør, der skal stå i spidsen for innovationsprogrammet Spark Denmark, som Novo Nordisk Fonden forleden kastede 44 mio. kr. efter for at bringe flere akademiske projekter indenfor farma, medico, sundhedsteknologi og industriel biotek til markedet.
QA Manager GMP/GDP Compliance & Audits 
GxP QA Compliance Manager for Quality Assurance 
Associate Director, International Medical Affairs 
Associate Director, Tax 
Senior Director, Global Regulatory Lead 
Senior HR Director, HR Denmark, Ferring 
Commercial Excellence Lead 
NORDIC Medical Sales Director 
Kemikere søges til ALKs interne Flyverkorps 
Project Lead, Muna Therapeutics, Copenhagen, Denmark 
Senior Quality Assurance Konsulent, Danmark 
Director Medical Science 
Director Regulatory Affairs 
KLIFO is looking for a Director, Business Support for our Glostrup office 
QA Specialist